COPD patient
Pennsylvania
About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.
Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for our patients and consumers and make GSK a brilliant place to work.
Our values are Patient Focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork.
Doing more in the US
Across the US, we employ more than 15,000 people - from our Vaccines R&D headquarters in Maryland, to our R&D Hub in Pennsylvania, and from one of our nearly 10 manufacturing sites across America, our employees and our values are at the heart of everything we do. This work starts one person, one community, and one story at a time .
What we do
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.
Pharmaceuticals
Our Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, use of genetics and advanced technologies.
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. We deliver over two million vaccine doses per day to people living in over 160 countries.
Consumer Healthcare
Our Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert recommended brands in the Pain relief, Respiratory, Digestive health, Oral health, Nutrition and Skin health categories.
How we do it
Everyone at GSK is focused on three priorities – Innovation, Performance, Trust
Innovation
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.
-
$5.1bn
R&D investment in 2018
-
33*
of the 46* new medicines now in development targeting modulation of the immune system
-
16*
immuno-oncology assets now in clinical development
Performance
We aim to achieve industry-leading growth by investing effectively in our business, developing our people and delivering flawlessly.
-
$40.9bn
total turnover in 2018
-
$11.5bn
adjusted operating profit in 2018
-
$7.5bn
free cash flow in 2018
-
$5.1bn
dividends paid in 2018
Trust
We commit to ensuring the quality, safety and reliable supply of our products; and to building trust through our approach to engagement, pricing, global health and being a modern employer.
-
78%
employee engagement score on our latest employee survey
-
$297m
donated in 2018 to community health programs
-
1st
in Access to Medicines Index since the assessment began in 2008
